Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Virbac SA (VIRP) EUR1.25

Sell:€210.00 Buy:€217.50 Change: €3.00 (1.35%)
Market closed |  Prices as at close on 8 March 2021 | Switch to live prices |
Change: €3.00 (1.35%)
Market closed |  Prices as at close on 8 March 2021 | Switch to live prices |
Change: €3.00 (1.35%)
Market closed |  Prices as at close on 8 March 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.

Contact details

13eme rue LID, Bp 27, Carros Cedex
+33 (4) 92087100

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€1.80 billion
Shares in issue:
8.44 million
Euronext Paris
Euronext Next 150

Key personnel

  • Marie-Helene Dick
    Chairwoman of the Supervisory Board
  • Sebastien Huron
    Chairman of the Management Board
  • Pierre Madelpuech
    Vice Chairman of the Supervisory Board
  • Habib Ramdani
    Chief Financial Officer, Member of the Management Board
  • Christian Karst
    General Manager, Executive Vice President - Corporate Development, Member of the Management Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.